Psychotropic-Drug-induced QT Prolongation and ECG Monitoring in the Pediatric Population
Recruiting
Observational Study
Eating Disorders
Mood Disorders in Children and Adolescents
Psychotic Disorder
QTc Intervals Changes
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- Up to 18
- Sex
- Any
- Study type
- Observational
- Participants needed
- 100 (estimated)
- Sponsor
- Meyer Children's Hospital IRCCS · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Electrocardiogram (ECG) Q-T prolongation is a cardiac electrophysiological disorder associated with the occurrence of arrhythmias potentially fatal. Several psychotropic drugs are associated with an increased risk of QT prolongation, which is why in clinical practice a baseline ECG is performed before a psychotropic drug is prescribed. However, there are no validated protocols establishing when to…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Admitted to psychiatry ward
* Starting a psychotropic drug acting on QT interval
Exclusion Criteria:
* Age \>18aa
* History of administration of drug acting on QT interval in the 3 months prior
Contacts